| Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack C Gur, Y Ibrahim, B Isaacson, R Yamin, J Abed, M Gamliel, J Enk, ... Immunity 42 (2), 344-355, 2015 | 1068 | 2015 |
| Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients EN Baruch, I Youngster, G Ben-Betzalel, R Ortenberg, A Lahat, L Katz, ... Science 371 (6529), 602-609, 2021 | 929 | 2021 |
| Characterization of the expression of MHC proteins in human embryonic stem cells M Drukker, G Katz, A Urbach, M Schuldiner, G Markel, J Itskovitz-Eldor, ... Proceedings of the National Academy of Sciences 99 (15), 9864-9869, 2002 | 830 | 2002 |
| Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients MJ Besser, R Shapira-Frommer, AJ Treves, D Zippel, O Itzhaki, ... Clinical cancer research 16 (9), 2646-2655, 2010 | 630 | 2010 |
| Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus TI Arnon, H Achdout, O Levi, G Markel, N Saleh, G Katz, R Gazit, ... Nature immunology 6 (5), 515-523, 2005 | 530 | 2005 |
| CXCL12 expression by invasive trophoblasts induces the specific migration of CD16–human natural killer cells J Hanna, O Wald, D Goldman-Wohl, D Prus, G Markel, R Gazit, G Katz, ... Blood 102 (5), 1569-1577, 2003 | 450 | 2003 |
| Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapies MJ Besser, R Shapira-Frommer, O Itzhaki, AJ Treves, DB Zippel, D Levy, ... Clinical Cancer Research 19 (17), 4792-4800, 2013 | 426 | 2013 |
| Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis E Shoshan, AK Mobley, RR Braeuer, T Kamiya, L Huang, ME Vasquez, ... Nature cell biology 17 (3), 311-321, 2015 | 232 | 2015 |
| Tumor and viral recognition by natural killer cells receptors TI Arnon, G Markel, O Mandelboim Seminars in cancer biology 16 (5), 348-358, 2006 | 230 | 2006 |
| Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence M Harel, R Ortenberg, SK Varanasi, KC Mangalhara, M Mardamshina, ... Cell 179 (1), 236-250. e18, 2019 | 224 | 2019 |
| CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity G Markel, N Lieberman, G Katz, TI Arnon, M Lotem, O Drize, RS Blumberg, ... The Journal of Immunology 168 (6), 2803-2810, 2002 | 219 | 2002 |
| Establishment and large-scale expansion of minimally cultured “young” tumor infiltrating lymphocytes for adoptive transfer therapy O Itzhaki, E Hovav, Y Ziporen, D Levy, A Kubi, D Zikich, L Hershkovitz, ... Journal of immunotherapy 34 (2), 212-220, 2011 | 212 | 2011 |
| Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function T Gonen-Gross, H Achdout, R Gazit, J Hanna, S Mizrahi, G Markel, ... The Journal of Immunology 171 (3), 1343-1351, 2003 | 178 | 2003 |
| MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth Y Nemlich, E Greenberg, R Ortenberg, MJ Besser, I Barshack, ... The Journal of clinical investigation 123 (6), 2703-2718, 2013 | 174 | 2013 |
| Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions G Markel, D Wolf, J Hanna, R Gazit, D Goldman-Wohl, Y Lavy, S Yagel, ... The Journal of clinical investigation 110 (7), 943-953, 2002 | 168 | 2002 |
| Rheumatic manifestations among cancer patients treated with immune checkpoint inhibitors M Lidar, E Giat, D Garelick, Y Horowitz, H Amital, Y Steinberg-Silman, ... Autoimmunity reviews 17 (3), 284-289, 2018 | 159 | 2018 |
| Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients MJ Besser, R Shapira-Frommer, AJ Treves, D Zippel, O Itzhaki, ... Journal of immunotherapy 32 (4), 415-423, 2009 | 156 | 2009 |
| Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease H Abu-Sbeih, DM Faleck, B Ricciuti, RB Mendelsohn, AR Naqash, ... Journal of Clinical Oncology 38 (6), 576, 2020 | 151 | 2020 |
| Triage and management of pericardial effusion M Imazio, BM Mayosi, A Brucato, G Markel, R Trinchero, DH Spodick, ... Journal of Cardiovascular Medicine 11 (12), 928-935, 2010 | 151 | 2010 |
| Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1 N Stern, G Markel, TI Arnon, R Gruda, H Wong, SD Gray-Owen, ... The Journal of Immunology 174 (11), 6692-6701, 2005 | 147 | 2005 |
